Add BrightSurf on Google Email

Study: Endometrial cancer rates are rising, and affecting Native American and Hispanic women at younger ages

Endometrial cancer rates have increased substantially among Native American and Hispanic women, diagnosed at younger ages, with significant disparities in healthcare access. Research highlights the need for increased awareness, earlier detection, and targeted interventions to address these disparities and reduce cancer-related deaths.

SourceUniversity of Arizona·JournalCancer Medicine·TypeData/statistical analysis·DateNov 13, 2026

Global burden of disease analysis finds China carries a larger absolute burden while the United States has higher age-standardized rates

China has more prevalent cases of pancreatic cancer (103,000 vs. 66,000), but lower age-standardized rates, compared to the US. The US has higher age-standardized rates of incidence, mortality, and disability-adjusted life years (DALYs), attributed to high fasting plasma glucose being the leading risk factor

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeData/statistical analysis·DateNov 13, 2026

Carol J. Levy, MD, CDCES, named Chief of Endocrinology, Diabetes and Bone Disease at Mount Sinai Health System

Carol J. Levy, MD, CDCES, has been appointed as Chief of the Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai Health System. Dr. Levy brings extensive experience in diabetes care, research, and education, having led the Mount Sinai Diabetes Center and established the outpatient artificial pancreas program.

Helmholtz Munich spin-off: New approach to type 2 diabetes moves towards clinical testing

Viacure Therapeutics, a spin-off from Helmholtz Munich, is developing an antibody therapy to protect insulin-producing beta cells and restore their function in type 2 diabetes. The therapy aims to preserve or regenerate beta cells, supporting the body's ability to regulate blood glucose.

World Diabetes Day (Nov.14): Bar-Ilan University researchers identify blood-based biomarkers that could help personalize treatment for autoimmune diabetes

Researchers at Bar-Ilan University have identified two blood biomarkers that can predict which mice will respond to a combination therapy for autoimmune diabetes, leading to long-term remission in one-third of treated mice. The study also showed that the treatment stimulated pancreatic regeneration, offering new insights into potential...

SourceBar-Ilan University·JournalMedComm·DateNov 9, 2026

Chinese Medical Journal article review explores AI-powered CGM data analysis in diabetes care

Researchers review how AI enhances continuous glucose monitoring to enable predictive, personalized diabetes management, improving glycemic outcomes and prioritizing high-risk patients. Machine learning models forecast individualized responses to meals, enabling tailored dietary and physical activity guidance.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeCommentary/editorial·DateNov 6, 2026

Good sleep linked to better brain health in cardiometabolic disease

Research from Karolinska Institutet found that people with type 2 diabetes, heart disease, or stroke who sleep well perform better on cognitive tests and have larger brain volumes than those who sleep poorly. This study suggests that healthy sleep may help mitigate the negative effects of cardiometabolic disease on brain health.

SourceKarolinska Institutet·JournalJournal of the American Heart Association·TypeObservational study·DateNov 4, 2026

Earlier bedtime linked to weight loss in prediabetes

A randomized controlled trial found that adding sleep coaching to a diabetes prevention lifestyle program helped participants sleep better and feel less sleepy during the day, leading to greater weight loss. Falling asleep earlier was associated with about 1.3 pounds of weight loss over eight weeks, independent of sleep duration.

SourceNew York University·JournalNursing Research·DateNov 2, 2026

Dr. Petter Bjornstad named Senior Vice Chancellor and Executive Director of LSU’s Pennington Biomedical Research Center

Dr. Petter Bjornstad will lead Pennington Biomedical Research Center in advancing research in metabolic disease, with a focus on improving the health and well-being of Louisiana residents. He brings exceptional expertise in diabetes and kidney disease, with a vision to translate world-class science into better health outcomes.

Burden of chronic kidney disease in China: trends, etiological shifts and key risk factors based on GBD 2023 data

Chronic kidney disease in China has seen rising prevalence, with 156 million people affected in 2023, largely driven by type-2 diabetes and hypertension, with obesity remaining a significant risk factor, and a disparity between men and women in disease burden

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateOct 27, 2026

Air pollution and temperature variability are associated with higher blood glucose levels

A European study found associations between air pollution, temperature variability, and blood glucose levels in people without diabetes. Greater exposure to air pollution, particularly PM10 particles, and increases in temperature and temperature variability were linked to higher blood glucose levels.

SourceGermans Trias i Pujol Research Institute·JournalEnvironment International·TypeObservational study·DateOct 21, 2026

Continuous glucose monitors help type 2 diabetes patients spend five more hours a day in healthy blood sugar range

A large-scale clinical trial found that adults using continuous glucose monitors (CGMs) spent approximately 5 additional hours each day within their target blood sugar range compared to those receiving routine care. Nearly twice as many CGM users achieved an A1c level below 7%, a common treatment goal for people with diabetes.

SourceUniversity of Colorado Anschutz·JournalNew England Journal of Medicine·DateOct 14, 2026

First 90 days after starting antipsychotics are critical for monitoring diabetes risk

A new study by UCL researchers highlights the importance of monitoring blood sugar and weight changes during the first 90 days after starting antipsychotic treatment. The study found significant metabolic changes during this period, particularly among patients with prediabetes and those who take certain antipsychotic medications.

SourceUniversity College London·JournalThe Lancet Psychiatry·TypeObservational study·DateOct 14, 2026

Food processing influences metabolism and brain activity

Researchers found that minimally and highly processed meals with matched nutritional profiles produced distinct metabolic responses and activity in the brain's reward system. The study suggests that food processing may affect how the body and brain respond to food, potentially leading to overconsumption and long-term health effects.

SourceVirginia Tech·JournalNature Metabolism·TypeExperimental study·DateOct 5, 2026

Pancreatic cancer burden rises in both China and the US, but patterns diverge

A new study finds that high fasting glucose has surpassed tobacco use as the leading risk factor for pancreatic cancer in the US, while China faces a dual metabolic-tobacco burden. China recorded more absolute cases, but lower age-standardized rates, with a peak burden at ages 60-74.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeData/statistical analysis·DateSep 30, 2026

New Trinity research suggests a simple pill could prevent sight loss in common form of diabetes-driven eye condition

Researchers have found that an oral medication called Danegaptide can protect against vision-threatening damage in Non-Proliferative Diabetic Retinopathy (NPDR), a leading cause of blindness in working-age adults. The study highlights a new therapeutic approach that could replace or complement frequent, invasive eye injections for mill...

SourceTrinity College Dublin·JournalScience Translational Medicine·DateSep 23, 2026

Eating with a loved one lowers your blood sugar

A new study found that eating with a companion reduces blood glucose spikes and improves glucose recovery, suggesting that human physiology is inherently social. The researchers call this principle Social Physiology, which states that the human body regulates itself more efficiently in the presence of social partners.

SourceThe Hebrew University of Jerusalem·JournalScience Advances·TypeExperimental study·DateSep 23, 2026

The European Association for the Study of Diabetes publishes its first-ever clinical guideline and the world's first to focus on diabetes distress

The EASD has published its first evidence-based clinical practice guideline on diabetes distress, emphasizing the importance of assessing and managing emotional burdens in adults with type 1 and type 2 diabetes. The guideline aims to improve clinical care and outcomes by incorporating a person-centered approach to diabetes care.

SourceEuropean Association for the Study of Diabetes·JournalDiabetologia·TypeSystematic review·DateSep 16, 2026

Pennington Biomedical researchers help advance new tool for analyzing continuous glucose monitoring data

Researchers at Pennington Biomedical developed GVC-Calc to analyze continuous glucose monitoring data, providing a scalable and transparent approach. The platform supports batch processing, integrates individual-level data with cohort-level results, and offers consensus clinical metrics alongside exploratory measures.

SourcePennington Biomedical Research Center·JournalNature Metabolism·TypeCommentary/editorial·DateSep 16, 2026

Study suggests that people with diabetes who are controlling their blood sugar too strictly (within safe limits) could be experiencing less enjoyment in life

A new study suggests that individuals with diabetes who focus on tightly controlling their blood sugar levels may be missing out on enjoyable activities due to the associated burden. Higher glucose variability and better sleep quality on the previous day were associated with improved quality of life on the following day.

Spinal cord stimulation eases pain and improves sensation in people with diabetic nerve damage

A clinical trial found significant improvements in pain and sensation in people with treatment-resistant painful diabetic neuropathy after receiving spinal cord stimulation. The study also observed early evidence of increased density of small nerve fibers in the skin, which may indicate potential long-term benefits.

Pennington Biomedical Research Center’s 2026 Childhood Obesity Conference: “Be the Reason Kids Greaux Healthy” to be held Sept. 24

The 2026 Childhood Obesity Conference, 'Be the Reason Kids Greaux Healthy,' will explore strategies for preventing and treating childhood obesity, bringing together healthcare professionals, researchers, educators, and community leaders. The conference will feature keynotes, sessions, and poster presentations on emerging topics in pedi...

Why one size doesn't fit all: study indicates type 2 diabetes operates differently across weight profiles

A study found that type 2 diabetes in lean Africans is caused by a shortage of insulin, not insulin resistance, unlike in overweight individuals. This disparity leads to different disease processes and treatment responses, with lean patients often developing eye damage and strokes, while overweight patients are more likely to have high...

SourceAmsterdam University Medical Center·JournalDiabetologia·TypeObservational study·DateAug 24, 2026